WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

66.66

-1.02%↓

Home・Akciju saraksts・USANA Health Sciences Inc

USANA Health Sciences Inc

Atvērts

18.9 -2.43

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

18.54

Max

19.37

Galvenie mērījumi
By Trading Economics
Ienākumi	5.1M -1.6M
Pārdošana	13M 226M
P/E Sektora vidējais	35.586 29.378
Peļņas marža	-0.705
Darbinieki	1,570
EBITDA	16M 28M

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 5. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-1.1M 381M
Iepriekšējā atvēršanas cena	21.33
Iepriekšējā slēgšanas cena	18.9

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

28.405 / 29.84 Atbalsts un pretestība

USANA Health Sciences Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 26. apr. 21:14 UTC

Galvenie ziņu notikumi

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

2026. g. 26. apr. 21:14 UTC

Galvenie ziņu notikumi

Week Ahead for FX, Bonds: Major Central Bank -2-

2026. g. 24. apr. 19:19 UTC

Iegādes, apvienošanās, pārņemšana

Intertek Group Rejects EQT's Revised Offer

2026. g. 26. apr. 23:48 UTC

Tirgus saruna

Nikkei May Rise After U.S. Tech Gains -- Market Talk

2026. g. 26. apr. 23:44 UTC

Peļņas

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

2026. g. 26. apr. 23:44 UTC

Peļņas

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

2026. g. 26. apr. 23:36 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Falls Amid Dollar's Strength -- Market Talk

2026. g. 26. apr. 23:33 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

2026. g. 26. apr. 05:12 UTC

Peļņas

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

2026. g. 26. apr. 05:12 UTC

Peļņas

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

2026. g. 26. apr. 05:12 UTC

Peļņas

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

2026. g. 26. apr. 05:12 UTC

Peļņas

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

2026. g. 24. apr. 23:37 UTC

Iegādes, apvienošanās, pārņemšana

Scoring the Cook Era -- Barrons.com

2026. g. 24. apr. 20:51 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 20:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 24. apr. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 24. apr. 20:39 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 20:09 UTC

Peļņas

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

2026. g. 24. apr. 19:48 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

2026. g. 24. apr. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

2026. g. 24. apr. 19:22 UTC

Peļņas

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

2026. g. 24. apr. 19:06 UTC

Peļņas

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

2026. g. 24. apr. 19:05 UTC

Tirgus saruna

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

2026. g. 24. apr. 18:30 UTC

Iegādes, apvienošanās, pārņemšana

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

2026. g. 24. apr. 18:28 UTC

Iegādes, apvienošanās, pārņemšana

Intertek Rejects Revised EQT Offer

2026. g. 24. apr. 18:12 UTC

Tirgus saruna

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

2026. g. 24. apr. 18:06 UTC

Tirgus saruna

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

2026. g. 24. apr. 17:42 UTC

Peļņas

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

2026. g. 24. apr. 17:28 UTC

Peļņas

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

USANA Health Sciences Inc Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 0 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam USANA Health Sciences Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

28.405 / 29.84Atbalsts un pretestība

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.